JOHN LEWANDOWSKI: Open Payments
NPI 1356943484 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,784 in 72 payments from 31 companies in 2025. Trend: 2023 $430 · 2024 $1,851 · 2025 $1,784
Food & beverage: $1,698Education: $86
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 9 | $299 |
| Novartis Pharmaceuticals Corporation | 7 | $188 |
| Merck Sharp & Dohme LLC | 6 | $137 |
| BeOne Medicines USA, Inc. | 5 | $119 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $102 |
| GlaxoSmithKline, LLC. | 5 | $101 |
| E.R. Squibb & Sons, L.L.C. | 2 | $79 |
| Incyte Corporation | 3 | $72 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $67 |
| ABBVIE INC. | 3 | $67 |
Products named: Enhertu, KEYTRUDA, KISQALI, Nubeqa, BRUKINSA, OPDIVO, VENCLEXTA, MONJUVI.
Industry payments across TN — which companies pay providers there.
